Veeva Systems Inc. (NYSE:VEEV) Stock Has Consensus Price Target of $284.88

Shares of Veeva Systems Inc. (NYSE:VEEV) have been given a consensus rating of “Moderate Buy” by the twenty-eight brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and nineteen have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $284.88.

Several research analysts have weighed in on the company. Mizuho lifted their target price on Veeva Systems from $270.00 to $280.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Robert W. Baird upped their price target on Veeva Systems from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. UBS Group lifted their price objective on shares of Veeva Systems from $190.00 to $290.00 and gave the company a “neutral” rating in a research report on Thursday, August 27th. Stifel Nicolaus set a $300.00 price objective on shares of Veeva Systems in a research note on Thursday, August 27th. Finally, BMO Capital Markets boosted their price objective on shares of Veeva Systems from $175.00 to $270.00 and gave the company a “market perform” rating in a research note on Thursday, August 27th.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Wall Street analysts reportedly see approximately 30% potential upside for Veeva, supporting the bullish case for the stock despite its recent weakness. Why Analysts See 30% Upside Ahead Analysts See Potential Rally
• Positive Sentiment: Veeva’s role as software infrastructure for pharmaceutical and biotechnology companies positions it to benefit from the use of artificial intelligence in medicine, including research, regulatory and commercial workflows. AI Will Revolutionize Medicine
• Positive Sentiment: Servier adopted Veeva OpenData globally to scale its AI initiatives, providing evidence of enterprise adoption and potential support for Veeva’s data and AI-related growth. Servier Adopts Veeva OpenData Globally
• Positive Sentiment: ACTO achieved Veeva Gold Product Partner status, potentially strengthening Veeva’s partner ecosystem and implementation capabilities. ACTO Achieved Veeva Gold Product Partner Status
• Neutral Sentiment: Commentary highlighting Veeva among software stocks that rebounded during the third quarter reinforces investor interest, but does not identify a new company-specific catalyst. Software Stocks and AI Commentary
• Negative Sentiment: Veeva declined while the overall market gained. The coverage offers no fresh earnings warning or negative operating update, so the move may reflect profit-taking and elevated valuation sensitivity after a strong run. Veeva Stock Sinks as Market Gains

Insider Activity

In related news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total value of $195,780.00. Following the completion of the sale, the director owned 3,242 shares in the company, valued at $846,291.68. This trade represents a 18.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Thomas D. Schwenger sold 10,000 shares of Veeva Systems stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the completion of the sale, the insider directly owned 19,449 shares in the company, valued at $5,471,587.17. This represents a 33.96% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 46,750 shares of company stock worth $12,017,360. Insiders own 10.60% of the company’s stock.

Hedge Funds Weigh In On Veeva Systems

A number of large investors have recently modified their holdings of VEEV. CX Institutional boosted its stake in shares of Veeva Systems by 72.3% in the third quarter. CX Institutional now owns 2,254 shares of the technology company’s stock valued at $643,000 after buying an additional 946 shares in the last quarter. Versant Capital Management Inc raised its position in Veeva Systems by 57.5% in the third quarter. Versant Capital Management Inc now owns 690 shares of the technology company’s stock worth $197,000 after acquiring an additional 252 shares in the last quarter. Burkett Financial Services LLC acquired a new stake in Veeva Systems in the third quarter valued at $27,000. QRG Capital Management Inc. lifted its holdings in Veeva Systems by 8.6% in the second quarter. QRG Capital Management Inc. now owns 16,280 shares of the technology company’s stock valued at $2,889,000 after acquiring an additional 1,284 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its position in shares of Veeva Systems by 8.6% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 28,344 shares of the technology company’s stock worth $5,030,000 after purchasing an additional 2,246 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Price Performance

Shares of NYSE:VEEV opened at $273.22 on Wednesday. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $310.50. The stock has a market cap of $44.24 billion, a P/E ratio of 44.94, a P/E/G ratio of 1.17 and a beta of 0.93. The firm has a fifty day moving average price of $252.60 and a 200 day moving average price of $200.16.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same period in the previous year, the business posted $1.99 earnings per share. Veeva Systems’s quarterly revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Sell-side analysts expect that Veeva Systems will post 6.7 EPS for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems Inc is a cloud software company that provides applications and services for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other organizations involved in developing, manufacturing and commercializing regulated products.

The company’s product portfolio includes the Veeva Vault platform, which supports areas such as clinical operations, regulatory affairs, quality management, safety and medical communications. Veeva also offers commercial and customer relationship management applications, data and analytics products, and services designed to help life sciences companies manage relationships with healthcare professionals, oversee content and improve operational efficiency.

Founded in 2007, Veeva serves customers globally and has expanded its offerings from commercial software into research, development, manufacturing and quality processes.